EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model.

Trial Profile

EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs AP 1531 (Primary)
  • Indications Headache
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jan 2011 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
    • 10 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top